Prelude Therapeutics secures $60M from Incyte option deal
Go back to Prelude Therapeutics secures $60M from Incyte option deal| Incyte Genomics, Inc. (NASDAQ: INCY) | Delayed: 118.87 +1.20 (1.02%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $117.67 | 52 Week High | $118.49 | |||
| Open | $117.67 | 52 Week Low | $55.00 | |||
| Day High | $120.71 | P/E | N/A | |||
| Day Low | $117.25 | EPS | $-0.56 | |||
| Volume | 2,728,922 | |||||
| (NASDAQ: PRLD) | Delayed: 3.89 +0.06 (1.57%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $3.83 | 52 Week High | $ | |||
| Open | $3.86 | 52 Week Low | $ | |||
| Day High | $4.05 | P/E | N/A | |||
| Day Low | $3.86 | EPS | $ | |||
| Volume | 179,540 | |||||
